American Well Co. (NYSE:AMWL) Receives Average Rating of "Hold" from Analysts

American Well Co. (NYSE:AMWL - Get Free Report) has been assigned an average rating of "Hold" from the six analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $11.90.

Several analysts have commented on AMWL shares. Truist Financial increased their price target on shares of American Well from $10.00 to $12.00 and gave the company a "hold" rating in a research report on Friday, February 14th. Stifel Nicolaus raised their target price on shares of American Well from $9.00 to $10.00 and gave the company a "hold" rating in a research note on Thursday, February 13th. Needham & Company LLC reaffirmed a "hold" rating on shares of American Well in a report on Thursday, February 13th. Wells Fargo & Company upgraded American Well from an "equal weight" rating to an "overweight" rating and set a $15.00 price objective for the company in a report on Monday, January 13th. Finally, Morgan Stanley dropped their target price on American Well from $20.00 to $10.50 and set an "equal weight" rating on the stock in a research note on Tuesday, December 17th.

Insider Activity

In related news, insider Phyllis Gotlib sold 4,781 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $8.80, for a total value of $42,072.80. Following the transaction, the insider now owns 147,998 shares in the company, valued at approximately $1,302,382.40. This represents a 3.13 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold 5,219 shares of company stock valued at $46,454 over the last ninety days. 12.80% of the stock is currently owned by insiders.

Remove Ads

Institutional Trading of American Well

Large investors have recently made changes to their positions in the business. BNP Paribas Financial Markets acquired a new position in American Well during the third quarter valued at $95,000. HighTower Advisors LLC acquired a new position in shares of American Well in the 3rd quarter valued at about $355,000. Compagnie Lombard Odier SCmA purchased a new stake in shares of American Well in the fourth quarter worth about $45,000. PDT Partners LLC acquired a new stake in American Well during the third quarter worth about $107,000. Finally, Walleye Capital LLC purchased a new position in American Well during the third quarter valued at approximately $167,000. 56.05% of the stock is owned by hedge funds and other institutional investors.

American Well Stock Up 1.3 %

Shares of NYSE AMWL traded up $0.10 during midday trading on Tuesday, reaching $7.99. 27,904 shares of the company's stock traded hands, compared to its average volume of 72,978. The company has a market cap of $124.72 million, a price-to-earnings ratio of -0.57 and a beta of 1.18. The stock's 50 day simple moving average is $9.95 and its 200-day simple moving average is $9.31. American Well has a one year low of $5.00 and a one year high of $18.80.

American Well (NYSE:AMWL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The company reported ($2.77) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.04) by $0.27. American Well had a negative return on equity of 56.73% and a negative net margin of 81.83%. Equities analysts predict that American Well will post -9.34 EPS for the current fiscal year.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.